Hi! 👋 We have a new venture. Please check out Satire Labs 😉.
The funniest way to turn your $100 to $1 million. ⛴️ 🚢.
Note: This is a joke. Kinda. We really do think you'll make money 😎🙂

  Biogen Inc ( BIIB ) |
1985 - 2021 (37 years)

Net Revenue (Sales) is 
$11.6B (1Y -14.1% )

BIIB Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for BIIB competitors.
AMGN CELG GILD SGMO ACOR BIO JNJ PFE SNY ABBV
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2021 $5.5B +1385x
( +21.6% / year avg)
chevron_left 1985 $4.0M
vertical_align_top Peak $14.3B +3564x
vertical_align_bottom Bottom $4.0M
arrow_drop_up # Up Years 33 33 of 37
years up.
arrow_drop_down # Down Years 4
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • BIIB's stock price has rallied +8,805% from $3.12 in 1985 , or +0.06x the rate relative to it's net revenue (sales) over the same period.
  • If BIIB grows it's stock at the same rate as it's net revenue (sales) (+21.6%/year) , it's stock price will grow +706% and hit $1967.13 over the next 10 years.
  • BIIB's stock price has gone up 0 of the 33 years (0%) it's net revenue (sales) were also up.
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997 FY 1996 FY 1995 FY 1994 FY 1993 FY 1992 FY 1991 FY 1990 FY 1989 FY 1988 FY 1987 FY 1986
    1 Revenue 13444600000.00 14377900000.00 13452900000.00 12273900000.00 11448800000.00 10763800000.00 9703324000.00 6932199000.00 5516461000.00 5048634000.00 4716423000.00 4377348000.00 4097507000.00 3171617000.00 1872185000.00 1713619000.00 1595819000.00 679183000.00 1148364000.00 1043360000.00 926452000.00 794435000.00 557587000.00 434044000.00 277090000.00 151691000.00 156344000.00 136400000.00 123700000.00 61400000.00 50100000.00 28500000.00 20600000.00 8600000.00 6400000.00
    2 Cost of Revenue 1805200000.00 1955400000.00 1816300000.00 1630000000.00 1478700000.00 1240400000.00 1171036000.00 857726000.00 545494000.00 466780000.00 400262000.00 382104000.00 401989000.00 335192000.00 274383000.00 373614000.00 554319000.00 284739000.00 160159000.00 136510000.00 125198000.00 111005000.00 74509000.00 50188000.00 28525000.00 10504000.00 9948000.00 5500000.00 2200000.00 43300000.00 35400000.00 25200000.00 21100000.00 21000000.00 23300000.00
    3 Gross Profit (Income) 11639400000.00 12422500000.00 11636600000.00 10643900000.00 9970100000.00 9523400000.00 8532288000.00 6074473000.00 4970967000.00 4581854000.00 4316161000.00 3995244000.00 3695518000.00 2836425000.00 1597802000.00 1340005000.00 1041500000.00 394444000.00 988205000.00 906850000.00 801254000.00 683430000.00 483078000.00 383856000.00 248565000.00 141187000.00 146396000.00 130900000.00 121500000.00 18100000.00 14700000.00 3300000.00 -500000.00 -12400000.00 -16900000.00
    4 R&D 3990900000.00 2280600000.00 2597200000.00 2253600000.00 1973300000.00 2012800000.00 1893422000.00 1444053000.00 1334919000.00 1219602000.00 1248604000.00 1283068000.00 1072058000.00 925164000.00 1048910000.00 747671000.00 687663000.00 1056337000.00 367567000.00 314556000.00 302840000.00 221153000.00 177228000.00 145501000.00 132384000.00 87448000.00 91213000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    5 SG&A 2504000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 232096000.00 170058000.00 146026000.00 115211000.00 90098000.00 73632000.00 40293000.00 24686000.00 102500000.00 85800000.00 14300000.00 10100000.00 9000000.00 8300000.00 8000000.00 8100000.00
    6 Other Expenses 2900000.00 -47000000.00 -10500000.00 -13100000.00 -17000000.00 -13800000.00 -8700000.00 -14900000.00 3700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    7 Operating Expenses 7193100000 5386800000 5635800000 5116100000 4317000000 4508500000 4615525000 3584409000 3132483000 2838137000 2747143000 2699817000 2456907000 1972841000 1991293000 1694734000 1613827000 1264113000 691568000 546652000 472898000 367179000 292439000 234888000 207736000 133742000 148303000 109200000 92900000 19400000 13900000 12300000 11400000 11800000 12200000
    8 Interest Expense 222500000.00 187400000.00 200600000.00 250800000.00 260000000.00 95500000.00 29500000.00 31900000.00 36500000.00 33000000.00 36100000.00 35800000.00 52000000.00 40500000.00 871000.00 9647000.00 18898000.00 15182000.00 3546000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    9 D&A 464800000.00 489900000.00 747300000.00 814700000.00 385600000.00 382600000.00 489761000.00 342948000.00 202204000.00 208566000.00 208928000.00 289811000.00 332745000.00 257495000.00 266998000.00 302305000.00 347677000.00 33180000.00 45100000.00 36913000.00 38824000.00 31099000.00 24590000.00 19296000.00 15264000.00 10916000.00 8056000.00 6700000.00 7100000.00 5100000.00 3800000.00 3300000.00 3100000.00 3800000.00 4100000.00
    10 EBITDA 4911100000.00 7525600000.00 6748100000.00 6342500000.00 6038700000.00 5397500000.00 4406524000.00 2833012000.00 2040688000.00 1952283000.00 1777946000.00 1585238000.00 1571356000.00 1121079000.00 -126493000.00 -52424000.00 -224650000.00 -836489000.00 341737000.00 397111000.00 367180000.00 347350000.00 215229000.00 168264000.00 56093000.00 18361000.00 6149000.00 28400000.00 35700000.00 3800000.00 4600000.00 -5700000.00 -8800000.00 -20400000.00 -25000000.00
    11 Operating Income 4446300000.00 7035700000.00 6000800000.00 5527800000.00 5653100000.00 5014900000.00 3916763000.00 2490064000.00 1838484000.00 1743717000.00 1569018000.00 1295427000.00 1238611000.00 863584000.00 -393491000.00 -354729000.00 -572327000.00 -869669000.00 296637000.00 360198000.00 328356000.00 316251000.00 190639000.00 148968000.00 40829000.00 7445000.00 -1907000.00 21700000.00 28600000.00 -1300000.00 800000.00 -9000000.00 -11900000.00 -24200000.00 -29100000.00
    12 Other Income Expenses (Net) 781700000.00 157600000.00 -13100000.00 -226700000.00 -523500000.00 -174200000.00 47151000.00 14245000.00 23665000.00 -18703000.00 -325312000.00 24552000.00 -174468000.00 -16089000.00 785306000.00 557820000.00 598093000.00 -29383000.00 -57713000.00 29299000.00 158749000.00 12765000.00 19554000.00 0.00 0.00 0.00 0.00 12900000.00 11400000.00 8700000.00 7200000.00 12400000.00 11000000.00 1800000.00 1300000.00
    13 Pre-Income Tax 5047500000.00 7125900000.00 5899600000.00 5128800000.00 4933000000.00 4767300000.00 3946633000.00 2480579000.00 1855105000.00 1711214000.00 1229906000.00 1332679000.00 1148943000.00 910595000.00 492163000.00 256195000.00 64093000.00 -880624000.00 276595000.00 389497000.00 487105000.00 329016000.00 210193000.00 148968000.00 40829000.00 7445000.00 -1907000.00 34600000.00 39900000.00 7500000.00 8000000.00 3400000.00 -900000.00 -22400000.00 -27800000.00
    14 Income Tax Expense 992300000.00 1158000000.00 1425600000.00 2458700000.00 1237300000.00 1161600000.00 989942000.00 601014000.00 470554000.00 444528000.00 331333000.00 355617000.00 365776000.00 272423000.00 278431000.00 95484000.00 39007000.00 -5527000.00 77447000.00 116814000.00 153528000.00 108566000.00 71496000.00 59801000.00 299000.00 1785000.00 2990000.00 2200000.00 1600000.00 300000.00 300000.00 200000.00 300000.00 200000.00 400000.00
    15 Net Income 4000600000.00 5888500000.00 4430700000.00 2539100000.00 3702800000.00 3547000000.00 2934784000.00 1862341000.00 1380033000.00 1234428000.00 1005273000.00 970132000.00 783167000.00 638172000.00 217511000.00 160711000.00 25086000.00 -875097000.00 199148000.00 272683000.00 333577000.00 220450000.00 138697000.00 89167000.00 40530000.00 5660000.00 -4897000.00 32400000.00 38300000.00 7200000.00 7700000.00 3200000.00 -1200000.00 -22600000.00 -28200000.00
    16 EPS 24.86 31.47 21.63 11.94 16.96 15.38 12.42 7.86 5.80 5.09 3.98 3.37 2.67 2.02 0.64 0.48 0.07 -4.92 1.33 1.84 0.75 0.49 0.31 0.20 0.09 0.03 -0.03 0.04 0.05 0.01 0.00 0.00 -0.00 -0.04 -0.06
    17 EPS Diluted 24.80 31.42 21.58 11.92 16.93 15.34 12.37 7.81 5.76 5.04 3.94 3.35 2.65 1.99 0.63 0.47 0.07 -4.92 1.31 1.78 0.72 0.47 0.30 0.20 0.04 0.01 -0.03 0.04 0.04 0.01 0.00 0.00 -0.00 -0.04 -0.06
    18 Shares Outstanding 156900000 187100000 204900000 212600000 218400000 230700000 236359000 236919000 237938000 242395000 252307000 287356000 292332000 315836000 338585000 335586000 334996000 177982000 149337000 148355000 446229000 449763000 442608000 442872000 439326000 218670000 196644000 747692308 820714286 675000000 540000000 120000000 360000000 521538462 470000000
    19 Shares Outstanding (Diluted) 156900000 187400000 205300000 213000000 218800000 231200000 237176000 238308000 239740000 245033000 254867000 289476000 294984000 320171000 345281000 346163000 343475000 177982000 151930000 152916000 463806000 473364000 462810000 459000000 922857143 705000000 196644000 810000000 851111111 675000000 540000000 120000000 360000000 521538462 470000000
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997 FY 1996 FY 1995 FY 1994 FY 1993 FY 1992 FY 1991 FY 1990 FY 1989 FY 1988 FY 1987 FY 1986
    1 Cash & Cash Equivalents 1331200000 2913700000 1224600000 1573800000 2326500000 1308000000 1204924000 602562000 570721000 514542000 759598000 581889000 622385000 659662000 661377000 568168000 209447000 314850000 45113000 54042000 48737000 56920000 25445000 70358000 62032000 45770000 54682000 74500000 85900000 56600000 12600000 33200000 54300000 54400000 70500000
    2 Short Term Investments 1278900000.00 1562200000.00 2313400000.00 2115200000.00 2568600000.00 2120500000.00 640460000.00 620167000.00 1134989000.00 1176115000.00 448146000.00 681835000.00 749032000.00 319408000.00 241314000.00 0.00 0.00 521109000.00 821996000.00 744065000.00 633675000.00 597619000.00 491469000.00 369730000.00 259349000.00 262178000.00 213120000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    3 Cash & S-T Investments 2610100000 4475900000 3538000000 3689000000 4895100000 3428500000 1845384000 1222729000 1705710000 1690657000 1207744000 1263724000 1371417000 979070000 902691000 568168000 209447000 835959000 867109000 798107000 682412000 654539000 516914000 440088000 321381000 307948000 267802000 74500000 85900000 56600000 12600000 33200000 54300000 54400000 70500000
    4 Accounts Receivables 2327300000.00 2470700000.00 2485400000.00 2319600000.00 1742200000.00 1541500000.00 1575805000.00 1077068000.00 955243000.00 813327000.00 839988000.00 744997000.00 653590000.00 559332000.00 486061000.00 406801000.00 416088000.00 315866000.00 171067000.00 177582000.00 143178000.00 137363000.00 101281000.00 86802000.00 42952000.00 19612000.00 18502000.00 31700000.00 33400000.00 18400000.00 13200000.00 5800000.00 1600000.00 2700000.00 1700000.00
    5 Inventory 1068600000.00 804200000.00 929900000.00 902700000.00 1001600000.00 893400000.00 804022000.00 659003000.00 447373000.00 326843000.00 289066000.00 293950000.00 263602000.00 233987000.00 169102000.00 182815000.00 251016000.00 496349000.00 95378000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    6 Other Current Assets 881100000.00 631000000.00 687600000.00 962000000.00 1093300000.00 836900000.00 447462000.00 226134000.00 136011000.00 144600000.00 22122000.00 177924000.00 169391000.00 596018000.00 154713000.00 78054000.00 119118000.00 66545000.00 43878000.00 77930000.00 62634000.00 67759000.00 49365000.00 31973000.00 23533000.00 12749000.00 8480000.00 203200000.00 149100000.00 134200000.00 95000000.00 80600000.00 1700000.00 700000.00 1400000.00
    7 Total Current Assets 6887100000 8381800000 7640900000 7873300000 8732200000 6700300000 4672673000 3184934000 3244337000 2975427000 2540420000 2480595000 2458000000 2368407000 1712567000 1618081000 1931044000 1838664000 1216024000 1097727000 928271000 910226000 694144000 596066000 435754000 340309000 294784000 309400000 268400000 209200000 120800000 119600000 57600000 57800000 73600000
    8 PP&E 3844800000 3674300000 3601200000 3182400000 2501800000 2187600000 1765700000 1750710000 1742226000 1571387000 1641634000 1637083000 1594754000 1497383000 1280385000 1174396000 1525225000 1252783000 738059000 555998000 400429000 239777000 182551000 174492000 165323000 115048000 73162000 38500000 32300000 28700000 23600000 15300000 14500000 14000000 18700000
    9 Goodwill 5762100000.00 5757800000.00 5706400000.00 4632500000.00 3669300000.00 2663800000.00 1760249000.00 1232916000.00 1201296000.00 1146314000.00 1146314000.00 1138621000.00 1138621000.00 1137372000.00 1154757000.00 1130430000.00 1151105000.00 1151066000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    10 Intangible Assets 3084300000.00 3527400000.00 3120000000.00 3879600000.00 3808300000.00 4085100000.00 4028500000.00 4474700000.00 1631500000.00 1608191000.00 1772826000.00 1871078000.00 2161058000.00 2492354000.00 2747241000.00 2975601000.00 3292827000.00 3638812000.00 15994000.00 16562000.00 13510000.00 13871000.00 15869000.00 14935000.00 10458000.00 7988000.00 8116000.00 7200000.00 6500000.00 7300000.00 6300000.00 4500000.00 3800000.00 3400000.00 3100000.00
    11 Goodwill & Intangible Assets 8846400000.00 9285200000.00 8826400000.00 8512100000.00 7477600000.00 6748900000.00 5788749000.00 5707616000.00 2832796000.00 2754505000.00 2919140000.00 3009699000.00 3299679000.00 3629726000.00 3901998000.00 4106031000.00 4443932000.00 4789878000.00 15994000.00 16562000.00 13510000.00 13871000.00 15869000.00 14935000.00 10458000.00 7988000.00 8116000.00 7200000.00 6500000.00 7300000.00 6300000.00 4500000.00 3800000.00 3400000.00 3100000.00
    12 L-T Investments 3671000000.00 2661000000.00 3067000000.00 3489000000.00 4165000000.00 3868000000.00 2225000000.00 1220000000.00 2311000000.00 1748000000.00 991000000.00 1424000000.00 1127000000.00 1133000000.00 1658000000.00 1468000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    13 Tax Assets 1369500000.00 3232100000.00 2153900000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Other Non-Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1204378000.00 1109624000.00 0.00 33154000.00 38576000.00 17664000.00 16082000.00 19483000.00 11237000.00 7034000.00 5856000.00 1800000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    15 Total Non-Current Assets 17731800000 18852500000 17648000000 15779300000 14144600000 12804500000 9643886000 8678401000 6885734000 6074177000 5552073000 6071259000 6020991000 6260408000 6840241000 6748866000 7234714000 7665281000 790964000 623319000 503585000 367747000 230571000 217759000 198818000 128892000 83078000 47600000 42800000 43900000 37700000 25600000 23300000 22900000 27300000
    16 Other Assets 4196000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 47000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    17 Total Assets 24618900000 27234300000 25288900000 23652600000 22876800000 19504800000 14316559000 11863335000 10130118000 9049604000 8092493000 8551854000 8478991000 8628815000 8552808000 8366947000 9165758000 9503945000 2006988000 1721046000 1431856000 1277973000 924715000 813825000 634572000 469201000 377862000 357000000 311200000 253100000 158500000 145200000 80900000 80700000 100900000
    18 Accounts Payables 454900000.00 530800000.00 370500000.00 395500000.00 279800000.00 267400000.00 229178000.00 219913000.00 203999000.00 186448000.00 162529000.00 118534000.00 107417000.00 90672000.00 100457000.00 99780000.00 121471000.00 63364000.00 64876000.00 50944000.00 37869000.00 30125000.00 24896000.00 15820000.00 15722000.00 12512000.00 9991000.00 2900000.00 3900000.00 3200000.00 2800000.00 1800000.00 0.00 0.00 0.00
    19 S-T Debt 7426000000.00 1495800000.00 0.00 3200000.00 4700000.00 4800000.00 3136000.00 3500000.00 453400000.00 3292000.00 137153000.00 19762000.00 27667000.00 1511135000.00 0.00 0.00 748430000.00 0.00 4888000.00 4888000.00 4888000.00 4888000.00 4888000.00 29705000.00 4017000.00 1667000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    20 Income Tax Payables 142000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    21 Deferred Revenue 0.00 0.00 0.00 0.00 0.00 55700000.00 120900000.00 172700000.00 148000000.00 0.00 41300000.00 0.00 0.00 0.00 0.00 16928000.00 13695000.00 7155000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    22 Other Current Liabilities 181500000.00 3368000000.00 0.00 0.00 0.00 0.00 2216570000.00 1754785000.00 1204010000.00 909597000.00 0.00 0.00 0.00 0.00 150680000.00 129155000.00 114035000.00 0.00 89824000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 28900000.00 22300000.00 10900000.00 9900000.00 4200000.00 0.00 0.00 0.00
    23 Total Current Liabilities 3742200000.00 4863800000.00 3295200000.00 3368200000.00 3419900000.00 2577700000.00 2219672000.00 1758298000.00 1657365000.00 912889000.00 1050122000.00 714942000.00 923222000.00 2189175000.00 582855000.00 583036000.00 1260748000.00 404825000.00 326333000.00 294942000.00 221021000.00 190270000.00 135089000.00 123883000.00 87948000.00 53395000.00 47928000.00 31800000.00 26200000.00 14100000.00 12700000.00 6000000.00 8000000.00 7600000.00 7200000.00
    24 L-T Debt 7426200000.00 4459000000.00 5936500000.00 5935000000.00 6512700000.00 6521500000.00 582100000.00 592400000.00 687400000.00 1060808000.00 1066379000.00 1080207000.00 1085431000.00 51843000.00 96694000.00 43444000.00 101879000.00 887270000.00 37410000.00 77272000.00 104433000.00 108173000.00 56960000.00 61846000.00 62254000.00 32826000.00 0.00 0.00 0.00 0.00 0.00 0.00 4800000.00 5200000.00 4400000.00
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997 FY 1996 FY 1995 FY 1994 FY 1993 FY 1992 FY 1991 FY 1990
    1 Net Income (Earnings) 4000600000.00 5888500000.00 4430700000.00 2539100000.00 3702800000.00 3547000000.00 2934784000.00 1862341000.00 1380033000.00 1234428000.00 1005273000.00 970132000.00 783167000.00 638172000.00 217511000.00 160711000.00 25086000.00 -875097000.00 199148000.00 272683000.00 333577000.00 220450000.00 138697000.00 89167000.00 40530000.00 5660000.00 -4897000.00 32400000.00 38300000.00 7200000.00 7700000.00
    2 D&A 457200000.00 680600000.00 1016600000.00 1081000000.00 682700000.00 600400000.00 688150000.00 531740000.00 365648000.00 358933000.00 354101000.00 427961000.00 462059000.00 380293000.00 375870000.00 402208000.00 439435000.00 61308000.00 45100000.00 36913000.00 38824000.00 31099000.00 24590000.00 19296000.00 15264000.00 10916000.00 8056000.00 -6700000.00 -7100000.00 -5100000.00 -3800000.00
    3 Deferred Income Tax 149000000.00 67100000.00 108300000.00 91700000.00 -175000000.00 -145600000.00 -308222000.00 -245077000.00 -116900000.00 153576000.00 -81410000.00 -137351000.00 -139549000.00 -81555000.00 -106337000.00 -90174000.00 8997000.00 -3894000.00 42203000.00 -18100000.00 25203000.00 -23981000.00 7486000.00 22462000.00 -5541000.00 0.00 0.00 0.00 0.00 0.00 0.00
    4 Stock-Based Compensation (SBC) 198300000.00 182300000.00 157500000.00 128000000.00 154800000.00 161400000.00 155302000.00 136293000.00 118566000.00 113005000.00 167826000.00 160902000.00 146207000.00 123129000.00 126783000.00 38145000.00 16795000.00 0.00 2356000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    5 Change in Working Capital -373100000.00 -827700000.00 -159400000.00 -807200000.00 1189700000.00 1669599000.00 1026365000.00 -160336000.00 -475566000.00 572240000.00 -275355000.00 230875000.00 1355546000.00 -950480000.00 94667000.00 364749000.00 -763543000.00 544148000.00 86906000.00 95535000.00 -12706000.00 160901000.00 86872000.00 124377000.00 60892000.00 40058000.00 -30744000.00 35400000.00 47100000.00 87000000.00 -5500000.00
    6 Accounts Receivables 179500000.00 5500000.00 -199500000.00 -667600000.00 -227500000.00 29000000.00 -512389000.00 -126753000.00 3571000.00 -73374000.00 -99227000.00 0.00 -57565000.00 -70701000.00 -37009000.00 6252000.00 -76529000.00 22618000.00 11788000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1700000.00 -15000000.00 -5200000.00 -7400000.00
    7 Inventory -316300000.00 -19200000.00 -52100000.00 -94500000.00 -165600000.00 -174400000.00 -185917000.00 -243960000.00 -140309000.00 -59219000.00 -4527000.00 -42772000.00 -54204000.00 -83192000.00 -36637000.00 -32732000.00 -90804000.00 -8720000.00 -50290000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    8 Accounts Payables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5500000.00 9600000.00 1600000.00 6600000.00
    9 Other Working Capital 3144900000 3518000000 4345700000 4505100000 5312300000 4122600000 2453001000 1426636000 1586972000 2062538000 1490298000 1765653000 1534778000 179232000 1129712000 1035045000 670296000 1433839000 889691000 802785000 707250000 719956000 559055000 472183000 347806000 286914000 246856000 277600000 242200000 195100000 108100000
    10 Other Non-Cash Items 119900000.00 5500000.00 31100000.00 344800000.00 91200000.00 82200000.00 -50320000.00 -27612000.00 58739000.00 77182000.00 277184000.00 9032000.00 955540000.00 763045000.00 562541000.00 278579000.00 413781000.00 244765000.00 0.00 30607000.00 -20675000.00 20449000.00 -888000.00 2695000.00 682000.00 -1748000.00 3484000.00 13100000.00 14600000.00 8900000.00 8400000.00
    11 Net Cash Provided by Operating Activities 4229800000.00 7078600000.00 6187700000.00 4551000000.00 4522400000.00 3716100000.00 2942115000.00 2345078000.00 1879897000.00 1727741000.00 1624673000.00 1074898000.00 1564492000.00 1020635000.00 841268000.00 889503000.00 727986000.00 219213000.00 267077000.00 316358000.00 365939000.00 272288000.00 167845000.00 97632000.00 46539000.00 9449000.00 34886000.00 47600000.00 43100000.00 5900000.00 10700000.00
    12 Investments in PP&E -551800000.00 -669500000.00 -886100000.00 -1962800000.00 -727700000.00 -643000000.00 -287751000.00 -3509000000.00 -261182000.00 -252175000.00 -173055000.00 -165646000.00 -275954000.00 -284106000.00 -198312000.00 -318376000.00 -369763000.00 -301248000.00 -221555000.00 -195534000.00 -199115000.00 -86327000.00 -33611000.00 -35550000.00 -65636000.00 -50309000.00 -43670000.00 -10800000.00 -9400000.00 -8400000.00 -11100000.00
    13 Acquisitions (Net) -1007000000.00 -121000000.00 -1963000000.00 -1200000000.00 -1200000000.00 -1049000000.00 -375000000.00 -15000000.00 -72000000.00 -5000000.00 -157000000.00 0.00 -25000000.00 -96000000.00 -303000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Purchase of Investments -6838700000 -5252600000 -8834300000 -5355200000 -7913200000 -6864900000 -3583150000 -3278091000 -3334434000 -3713319000 -1992886000 -3592205000 -3184197000 -2968916000 -1959365000 -1454147000 -3213051000 -1233251000 -467256000 -827807000 -627168000 -1120218000 -574021000 -481783000 -369893000 -349025000 -26625000 -53200000 -11600000 -37300000 -15300000
    15 Sales/Maturities of Investments 7374300000.00 6486300000.00 9173700000.00 5565900000.00 7378900000.00 4063000000.00 2718923000.00 5190052000.00 2759616000.00 2317993000.00 2668694000.00 3332829000.00 2941060000.00 3253779000.00 1787139000.00 1782134000.00 3200386000.00 1118775000.00 405301000.00 770426000.00 726286000.00 1006465000.00 453952000.00 373130000.00 370252000.00 307021000.00 0.00 0.00 0.00 0.00 0.00
    16 Other Investing Activities -26900000.00 27000000.00 400000.00 -11000000.00 -22800000.00 -59900000.00 -15998000.00 7371000.00 -41941000.00 0.00 0.00 29991000.00 178218000.00 -208209000.00 0.00 0.00 0.00 0.00 0.00 0.00 -5000000.00 -10000000.00 -5000000.00 -11000000.00 -16774000.00 0.00 0.00 -2700000.00 -2900000.00 -2600000.00 -3100000.00
    17 Net Cash used for Investing Activities -608600000 470500000 -2046300000 -2963100000 -2484800000 -4553600000 -1542976000 -1604668000 -950342000 -1650294000 345325000 -395031000 -365873000 -286572000 -599773000 417741000 -382428000 -278931000 -289510000 -252915000 -104997000 -210080000 -158680000 -155203000 -82051000 -92313000 -70295000 -66700000 -23900000 -48300000 -29500000
    18 Debt Repayment -1500000000.00 0.00 -3200000.00 -560900000.00 -2700000.00 -2100000.00 -2674000.00 -452340000.00 -2428000.00 -11459000.00 -18073000.00 -10867000.00 -1512474000.00 -18605000.00 0.00 -746416000.00 0.00 0.00 -4887000.00 -4888000.00 -4888000.00 -4887000.00 -29703000.00 -4082000.00 -1666000.00 -833000.00 0.00 0.00 0.00 0.00 0.00
    19 Common Stock Issued 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 314650000.00 183486000.00 47810000.00 178486000.00 489180000.00 146959000.00 119619000.00 273535000.00 24439000.00 27379000.00 35034000.00 35955000.00 171871000.00 41175000.00 24453000.00 19996000.00 0.00 15545000.00 0.00 0.00 0.00 0.00
    20 Common Stock Repurchased -6679100000.00 -5868300000.00 -4352600000.00 -1365400000.00 -1000000000.00 -5000000000.00 -886779000.00 -400309000.00 -984715000.00 -497975000.00 -2077579000.00 -751170000.00 -738938000.00 -2991184000.00 -320268000.00 -322590000.00 -734427000.00 0.00 -8384000.00 -88284000.00 -300192000.00 -197717000.00 -65550000.00 -7000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    21 Dividends Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2900000.00 -5900000.00
    22 Other Financing Activities -56400000.00 7900000.00 -114100000.00 -448400000.00 -28800000.00 3800000.00 78693000.00 69351000.00 42172000.00 -125078000.00 115466000.00 -9924000.00 -150726000.00 272476000.00 24899000.00 -9639000.00 9931000.00 0.00 153000.00 0.00 0.00 0.00 0.00 23164000.00 0.00 39459000.00 0.00 7800000.00 10000000.00 89400000.00 4100000.00
    23 Net Cash Used Provided by Financing Activities -5272700000.00 -5860400000.00 -4472000000.00 -2380000000.00 -987800000.00 986400000.00 -755873000.00 -716528000.00 -877478000.00 -319862000.00 -1784919000.00 -724151000.00 -1236672000.00 -735220000.00 -148410000.00 -948523000.00 -450961000.00 24439000.00 14261000.00 -58138000.00 -269125000.00 -30733000.00 -54078000.00 65897000.00 51774000.00 73952000.00 15545000.00 7800000.00 10000000.00 86500000.00 -1800000.00
    24 Net Change in Cash -1582500000.00 1689100000.00 -349200000.00 -752700000.00 1018500000.00 103100000.00 602362000.00 31841000.00 56179000.00 -245056000.00 177709000.00 -40496000.00 -37277000.00 -1715000.00 93209000.00 358721000.00 -105403000.00 -35279000.00 -8929000.00 5305000.00 -8183000.00 31475000.00 -44913000.00 8326000.00 16262000.00 -8912000.00 -19864000.00 0.00 0.00 0.00 0.00
  • About
    Industry: Drug Manufacturers General
    Sector: Healthcare
    Country: US
    IPO Date: 9/17/1991
    Stonk Exchange: NASDAQ
    • Biogen, Inc
    • is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases.
    • The company is headquartered in Cambridge, Massachusetts and currently employs 7,800 full-time employees.
    • The firm focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases.
    • The firm markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA).
    • The company also has a collaboration agreement with Genentech, Inc.
    • (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies.
    • The firm's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.